The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

While the prevalence of VISA and VRSA remains low, concerns about vancomycin resistance and the lack of a clinical or bacteriological response with as many as 18% of MRSA isolates with a ...

Antimicrobial resistance (AMR) data from 2012 through 2022 shows that the number of drug-resistant infections in hospitals has largely gone down, though it is still significant, according to a study ...

To make MRSA matters even worse, in 2002, health care workers reported the first cases of vancomycin-resistant MRSA. In other words, even "last-resort" vancomycin doesn't always work. Therein lies ...

Of the 1751 eligible infants, 83% (n = 1725), 75% (n = 1566) and 71% (n = 1475) were cultured for MRSA, VRE and AR-GNR, respectively. The rate of obtaining surveillance cultures increased during ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...